Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Boehringer Ingelheim
Dow
Johnson and Johnson
Harvard Business School

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Mupirocin calcium - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic sources for mupirocin calcium and what is the scope of patent protection?

Mupirocin calcium is the generic ingredient in two branded drugs marketed by Glaxosmithkline and Glenmark Pharms Inc, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for mupirocin calcium. Three suppliers are listed for this compound.

Summary for mupirocin calcium
Recent Clinical Trials for mupirocin calcium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institute of Allergy and Infectious Diseases (NIAID)Phase 2
Taro Pharmaceuticals USAPhase 1

See all mupirocin calcium clinical trials

Pharmacology for mupirocin calcium
Synonyms for mupirocin calcium
(alphaE,2S,3R,4R,5S)-5-((2S,3S,4S,5S)-2,3-Epoxy-5-hydroxy-4-methylhexyl)tetrahydro-3,4-dihydroxy-beta-methyl-2H-pyran-2-crotonic acid, ester with 9-hydroxynonanoic acid, calcium salt (2:1), dihydrate
104486-81-9
115074-43-6
115183-39-6
2C26H43O9.2H2O.Ca
573951-40-3
870F25Y7EK
AC1NQZV4
AC1O5KR4
AC1O64UJ
AKOS015994705
AN-33198
Bactroban (TN)
Bactroban Nasal
BRL 4910F
BRL-4910F
calcium 9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methyl-propyl]oxiran-2-yl]methyl]tetrahydropyran-2-yl]-3-methyl-but-2-enoyl]oxynonanoate dihydrate
calcium 9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoate
calcium 9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoate dihydrate
calcium 9-[(E)-4-[3,4-dihydroxy-5-[[3-(3-hydroxybutan-2-yl)oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid dihydrate
Calcium mupirocin
Calcium mupirocin dehydrate
calcium;9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoate;dihydrate
CHEMBL2068726
CHEMBL3989715
D02195
DDHVILIIHBIMQU-YJGQQKNPSA-L
HAXVBVDETFUQGV-LNQHITRNSA-L
Jsp001106
KS-1208
L-talo-Non-2-enoic acid, 5,9-anhydro-2,3,4,8-tetradeoxy-8-((3-(2-hydroxy-1-methylpropyl)oxiranyl)methyl)-3-methyl-, 8-carboxyoctyl ester, calcium salt (2:1), (2E,8(2S,3S(1S,2S)))-
L-talo-Non-2-enonic acid, 5,9-anhydro-2,3,4,8-tetradeoxy-8-(((2S,3S)-3-((1S,2S)-2-hydroxy-1-methylpropyl)oxiranyl)methyl)-3-methyl-, 8-carboxyoctyl ester, calium salt (2:1), (2E)-
LS-96885
MolPort-009-194-219
Mupirocin calcium (USAN)
Mupirocin calcium [USAN:USP]
Mupirocin calcium [USAN]
Mupirocin calcium anhydrous
Mupirocin calcium dihydrate
mupirocin calcium hydrate
Mupirocin calcium hydrate (JP17)
mupirocin calcium salt
Mupirocin, Calcium Salt (2:1), Dihydrate
Nonanoic acid, 9-((3-methyl-1-oxo-4-(tetrahydro-3,4-dihydroxy-5-((3-(2-hydroxy-1-methylpropyl)oxiranyl)methyl)-2H-pyran-2-yl)-2-butenyl)oxy)-, calcium salt (2:1) (2S-(2alpha(E),3beta,4beta,5alpha(2R*,3R*(1R*,2R*))))-
RG38I2P540
SCHEMBL412910
Turixin
UNII-870F25Y7EK
UNII-RG38I2P540

US Patents and Regulatory Information for mupirocin calcium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Pharms Inc MUPIROCIN mupirocin calcium CREAM;TOPICAL 201587-001 Jan 24, 2013 RX No Yes   Start Trial   Start Trial   Start Trial
Glaxosmithkline BACTROBAN mupirocin calcium OINTMENT;NASAL 050703-001 Sep 18, 1995 DISCN Yes No   Start Trial   Start Trial   Start Trial
Glaxosmithkline BACTROBAN mupirocin calcium CREAM;TOPICAL 050746-001 Dec 11, 1997 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for mupirocin calcium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline BACTROBAN mupirocin calcium CREAM;TOPICAL 050746-001 Dec 11, 1997   Start Trial   Start Trial
Glaxosmithkline BACTROBAN mupirocin calcium OINTMENT;NASAL 050703-001 Sep 18, 1995   Start Trial   Start Trial
Glaxosmithkline BACTROBAN mupirocin calcium CREAM;TOPICAL 050746-001 Dec 11, 1997   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Baxter
Express Scripts
Colorcon
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.